Logo image of R3NK.DE

RENK GROUP AG (R3NK.DE) Stock Fundamental Analysis

FRA:R3NK - Deutsche Boerse Ag - DE000RENK730 - Common Stock - Currency: EUR

35.51  -2.52 (-6.64%)

Fundamental Rating

3

Overall R3NK gets a fundamental rating of 3 out of 10. We evaluated R3NK against 105 industry peers in the Machinery industry. While R3NK seems to be doing ok healthwise, there are quite some concerns on its profitability. R3NK is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

R3NK had positive earnings in the past year.
In the past year R3NK had a positive cash flow from operations.
R3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFR3NK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 20M -20M 40M 60M 80M 100M

1.2 Ratios

With a Return On Assets value of 1.38%, R3NK perfoms like the industry average, outperforming 40.38% of the companies in the same industry.
R3NK has a Return On Equity (5.26%) which is in line with its industry peers.
R3NK has a Return On Invested Capital of 5.90%. This is comparable to the rest of the industry: R3NK outperforms 53.85% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for R3NK is below the industry average of 8.45%.
The 3 year average ROIC (4.10%) for R3NK is below the current ROIC(5.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 1.38%
ROE 5.26%
ROIC 5.9%
ROA(3y)0.87%
ROA(5y)N/A
ROE(3y)3.25%
ROE(5y)N/A
ROIC(3y)4.1%
ROIC(5y)N/A
R3NK.DE Yearly ROA, ROE, ROICR3NK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 5 -5 -10

1.3 Margins

R3NK has a Profit Margin (1.94%) which is in line with its industry peers.
Looking at the Operating Margin, with a value of 8.61%, R3NK is in the better half of the industry, outperforming 71.15% of the companies in the same industry.
R3NK's Operating Margin has improved in the last couple of years.
R3NK has a worse Gross Margin (22.95%) than 73.08% of its industry peers.
R3NK's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.61%
PM (TTM) 1.94%
GM 22.95%
OM growth 3Y2.38%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5YN/A
R3NK.DE Yearly Profit, Operating, Gross MarginsR3NK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 10 -10 20

4

2. Health

2.1 Basic Checks

R3NK has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, R3NK has about the same amount of shares outstanding.
The debt/assets ratio for R3NK has been reduced compared to a year ago.
R3NK.DE Yearly Shares OutstandingR3NK.DE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
R3NK.DE Yearly Total Debt VS Total AssetsR3NK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500M 1B

2.2 Solvency

An Altman-Z score of 3.20 indicates that R3NK is not in any danger for bankruptcy at the moment.
R3NK has a Altman-Z score of 3.20. This is amongst the best in the industry. R3NK outperforms 80.77% of its industry peers.
The Debt to FCF ratio of R3NK is 8.08, which is on the high side as it means it would take R3NK, 8.08 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of R3NK (8.08) is comparable to the rest of the industry.
A Debt/Equity ratio of 1.37 is on the high side and indicates that R3NK has dependencies on debt financing.
R3NK has a Debt to Equity ratio of 1.37. This is amonst the worse of the industry: R3NK underperforms 80.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF 8.08
Altman-Z 3.2
ROIC/WACC0.89
WACC6.61%
R3NK.DE Yearly LT Debt VS Equity VS FCFR3NK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.83 indicates that R3NK should not have too much problems paying its short term obligations.
R3NK has a better Current ratio (1.83) than 64.42% of its industry peers.
R3NK has a Quick Ratio of 1.83. This is a bad value and indicates that R3NK is not financially healthy enough and could expect problems in meeting its short term obligations.
R3NK has a Quick ratio of 0.92. This is comparable to the rest of the industry: R3NK outperforms 42.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.83
Quick Ratio 0.92
R3NK.DE Yearly Current Assets VS Current LiabilitesR3NK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 200M 400M 600M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.43% over the past year.
Looking at the last year, R3NK shows a quite strong growth in Revenue. The Revenue has grown by 9.01% in the last year.
The Revenue has been growing by 81.43% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)100.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.82%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y81.43%
Revenue growth 5YN/A
Sales Q2Q%10.52%

3.2 Future

R3NK is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.82% yearly.
The Revenue is expected to grow by 15.13% on average over the next years. This is quite good.
EPS Next Y-3.78%
EPS Next 2Y16.96%
EPS Next 3Y19.3%
EPS Next 5Y19.82%
Revenue Next Year21.06%
Revenue Next 2Y17.96%
Revenue Next 3Y16.62%
Revenue Next 5Y15.13%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
R3NK.DE Yearly Revenue VS EstimatesR3NK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
R3NK.DE Yearly EPS VS EstimatesR3NK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.5 1 1.5 2

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 177.55, the valuation of R3NK can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of R3NK indicates a slightly more expensive valuation: R3NK is more expensive than 62.50% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of R3NK to the average of the S&P500 Index (29.35), we can say R3NK is valued expensively.
With a Price/Forward Earnings ratio of 27.33, R3NK can be considered very expensive at the moment.
68.27% of the companies in the same industry are cheaper than R3NK, based on the Price/Forward Earnings ratio.
R3NK's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 22.10.
Industry RankSector Rank
PE 177.55
Fwd PE 27.33
R3NK.DE Price Earnings VS Forward Price EarningsR3NK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, R3NK is valued a bit more expensive than 73.08% of the companies in the same industry.
R3NK's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. R3NK is more expensive than 63.46% of the companies in the same industry.
Industry RankSector Rank
P/FCF 53.48
EV/EBITDA 23.86
R3NK.DE Per share dataR3NK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A more expensive valuation may be justified as R3NK's earnings are expected to grow with 19.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y16.96%
EPS Next 3Y19.3%

1

5. Dividend

5.1 Amount

With a yearly dividend of 0.79%, R3NK is not a good candidate for dividend investing.
R3NK's Dividend Yield is comparable with the industry average which is at 3.07.
With a Dividend Yield of 0.79, R3NK pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 0.79%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
R3NK.DE Yearly Dividends per shareR3NK.DE Yearly Dividends per shareYearly Dividends per share 2024 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

DPN/A
EPS Next 2Y16.96%
EPS Next 3Y19.3%
R3NK.DE Yearly Income VS Free CF VS DividendR3NK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2020 2021 2022 2023 0 20M -20M 40M 60M 80M

RENK GROUP AG

FRA:R3NK (3/7/2025, 7:00:00 PM)

35.51

-2.52 (-6.64%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)11-13 2024-11-13/bmo
Earnings (Next)03-26 2025-03-26
Inst Owners19.25%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.55B
Analysts86.32
Price Target34.39 (-3.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.79%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.02%
Min EPS beat(2)6.21%
Max EPS beat(2)19.83%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.44%
Min Revenue beat(2)-1.55%
Max Revenue beat(2)2.43%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.57%
PT rev (3m)7.44%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-3.3%
EPS NY rev (3m)-14.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)1.78%
Revenue NY rev (3m)1.78%
Valuation
Industry RankSector Rank
PE 177.55
Fwd PE 27.33
P/S 3.38
P/FCF 53.48
P/OCF 33.73
P/B 9.15
P/tB 127.19
EV/EBITDA 23.86
EPS(TTM)0.2
EY0.56%
EPS(NY)1.3
Fwd EY3.66%
FCF(TTM)0.66
FCFY1.87%
OCF(TTM)1.05
OCFY2.96%
SpS10.51
BVpS3.88
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.38%
ROE 5.26%
ROCE 8.5%
ROIC 5.9%
ROICexc 6.36%
ROICexgc 10.01%
OM 8.61%
PM (TTM) 1.94%
GM 22.95%
FCFM 6.32%
ROA(3y)0.87%
ROA(5y)N/A
ROE(3y)3.25%
ROE(5y)N/A
ROIC(3y)4.1%
ROIC(5y)N/A
ROICexc(3y)4.67%
ROICexc(5y)N/A
ROICexgc(3y)8.02%
ROICexgc(5y)N/A
ROCE(3y)5.91%
ROCE(5y)N/A
ROICexcg growth 3Y58.83%
ROICexcg growth 5YN/A
ROICexc growth 3Y58.8%
ROICexc growth 5YN/A
OM growth 3Y2.38%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.98%
GM growth 5YN/A
F-Score7
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 1.37
Debt/FCF 8.08
Debt/EBITDA 3.16
Cap/Depr 50.37%
Cap/Sales 3.7%
Interest Coverage 250
Cash Conversion 62.76%
Profit Quality 325.06%
Current Ratio 1.83
Quick Ratio 0.92
Altman-Z 3.2
F-Score7
WACC6.61%
ROIC/WACC0.89
Cap/Depr(3y)35.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)3.6%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-103.82%
EPS Next Y-3.78%
EPS Next 2Y16.96%
EPS Next 3Y19.3%
EPS Next 5Y19.82%
Revenue 1Y (TTM)9.01%
Revenue growth 3Y81.43%
Revenue growth 5YN/A
Sales Q2Q%10.52%
Revenue Next Year21.06%
Revenue Next 2Y17.96%
Revenue Next 3Y16.62%
Revenue Next 5Y15.13%
EBIT growth 1Y44.95%
EBIT growth 3Y85.75%
EBIT growth 5YN/A
EBIT Next Year42.98%
EBIT Next 3Y27.17%
EBIT Next 5Y23.65%
FCF growth 1Y-41%
FCF growth 3Y239.33%
FCF growth 5YN/A
OCF growth 1Y-30.02%
OCF growth 3Y68.58%
OCF growth 5YN/A